High Pointe Capital Management’s Biogen BIIB Stock Holding History

High Pointe Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-3,010	Closed	-$854K	–	88
2020 Q3	$854K	Sell	3,010 -60	-2%	-$16.7K	1.04%	42
2020 Q2	$821K	Buy	+3,070	New	+$923K	1.08%	40
2018 Q3	–	Sell	-2,430	Closed	-$705K	–	84
2018 Q2	$705K	Sell	2,430 -30	-1%	-$8.43K	1.01%	42
2018 Q1	$674K	Buy	2,460 +100	+4%	+$31K	0.93%	45
2017 Q4	$752K	Sell	2,360 -1,800	-43%	-$577K	1.03%	41
2017 Q3	$1.3M	Buy	4,160 +40	+1%	+$11.8K	1.91%	19
2017 Q2	$1.12M	Buy	4,120 +30	+0.7%	+$7.93K	1.73%	22
2017 Q1	$1.12M	Sell	4,090 -60	-1%	-$17K	1.77%	20
2016 Q4	$1.18M	Sell	4,150 -850	-17%	-$252K	1.93%	17
2016 Q3	$1.56M	Sell	5,000 -1,410	-22%	-$418K	2.78%	6
2016 Q2	$1.55M	Buy	6,410 +830	+15%	+$219K	2.36%	12
2016 Q1	$1.45M	Sell	5,580 -6,370	-53%	-$1.68M	2.1%	19
2015 Q4	$3.66M	Buy	11,950 +3,310	+38%	+$951K	1.8%	6
2015 Q3	$2.52M	Buy	8,640 +120	+1%	+$39.6K	1.18%	16
2015 Q2	$3.44M	Hold	8,520	–	–	1.23%	12
2015 Q1	$3.6M	Buy	8,520 +3,620	+74%	+$1.43M	1.29%	12
2014 Q4	$1.66M	Buy	+4,900	New	+$1.59M	0.73%	58

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

High Pointe Capital Management's BIIB Position: Q4 2020 in Review

High Pointe Capital Management sold out of Biogen (BIIB) in Q4 2020, closing a stake of 3,010 shares — an estimated $854K sold.

High Pointe Capital Management first reported a position in BIIB in Q4 2014 and held it in 17 quarters. The position peaked at $3.66M in Q4 2015. 1,061 funds tracked by Wall St. Rank hold BIIB as of Q4 2020.

High Pointe Capital Management reported no remaining Biogen position as of Q4 2020 after selling out during the quarter.
High Pointe Capital Management sold 3,010 Biogen shares in Q4 2020, an estimated $854K.
High Pointe Capital Management first reported a position in Biogen in Q4 2014 and held it in 17 quarters.
High Pointe Capital Management's Biogen position peaked at $3.66M in Q4 2015.
1,061 funds tracked by Wall St. Rank held Biogen as of Q4 2020.

Based on High Pointe Capital Management's 13F filing for Q4 2020, filed 8 Feb 2021.